STRATA Skin Sciences (SSKN) Shareholder's Equity Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | STRATA Skin Sciences | - | - | 5.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -35.42% |
| Sep 30, 2025 | -44.92% |
| Jun 30, 2025 | -54.33% |
| Mar 31, 2025 | -36.14% |
| Dec 31, 2024 | -29.55% |
| Sep 30, 2024 | -20.09% |
| Jun 30, 2024 | -20.25% |
| Mar 31, 2024 | -20.78% |
| Dec 31, 2023 | -16.49% |
| Sep 30, 2023 | -11.97% |
| Jun 30, 2023 | -11.34% |
| Mar 31, 2023 | 1.82% |
| Dec 31, 2022 | 1.89% |
| Sep 30, 2022 | 0.99% |
| Jun 30, 2022 | 10.02% |
| Mar 31, 2022 | 16.31% |
| Dec 31, 2021 | 11.07% |
| Sep 30, 2021 | 10.52% |
| Jun 30, 2021 | 8.36% |
| Mar 31, 2021 | 9.93% |
| Dec 31, 2020 | 9.99% |
| Sep 30, 2020 | 10.31% |
| Jun 30, 2020 | -0.35% |
| Dec 31, 2019 | 18.47% |
| Sep 30, 2019 | 13.64% |
| Jun 30, 2019 | 32.76% |
| Mar 31, 2019 | 36.61% |
| Dec 31, 2018 | 30.37% |
| Sep 30, 2018 | 24.38% |
| Jun 30, 2018 | 11.98% |
| Mar 31, 2018 | -5.51% |
| Dec 31, 2017 | 7.30% |
| Sep 30, 2017 | 3.38% |
| Jun 30, 2017 | -6.43% |
| Mar 31, 2017 | -14.49% |
| Dec 31, 2016 | -12.79% |
| Sep 30, 2016 | -3.37% |
| Jun 30, 2016 | -5.39% |
| Dec 31, 2015 | -12.74% |